Clinical trial
SHR-1316 Combined With Chemotherapy and Chest Radiotherapy in ES-SCLC
NCT04562337
Study timeline
Study start (actual)2020-10-01Date precision: day
Registry last updated2024-07-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Extensive-stage Small Cell Lung Cancerunresolved
Interventions
SHR1316DRUG
CarboplatinDRUG · verified · RxNorm: carboplatin
EtoposideDRUG · verified · RxNorm: etoposide
Radiation therapyRADIATION
CisplatinDRUG · verified · RxNorm: cisplatin
Sponsors & collaborators
Shandong Cancer Hospital and Institutelead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04562337 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.